 | • レポートコード：QYR9ST08894 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、がん用二重特異性抗体の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、CD19 / CD3、CD30 / CD16Aに、用途別には、病院、製薬会社、その他にセグメント区分し、がん用二重特異性抗体の世界市場を分析しました。 ・エグゼクティブ・サマリー ・がん用二重特異性抗体の世界市場概要 ・がん用二重特異性抗体の製造コスト構成分析 ・がん用二重特異性抗体の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・がん用二重特異性抗体の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・がん用二重特異性抗体のセグメント分析（種類別） （CD19 / CD3、CD30 / CD16A） ・がん用二重特異性抗体のセグメント分析（用途別） （病院、製薬会社、その他） ・がん用二重特異性抗体の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Amgen、Astella Pharma、Ben Kang Biopharmaceutical (Shenzhen)、Merus、Regeneron Pharmaceuticals） ・がん用二重特異性抗体の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
Bispecific antibodies can simultaneously address two different antigens, which are sufficient to target two trails involved in cancer pathogenesis, and therefore, provide advantages over monoclonal antibodies therapy.
The global Bispecific Antibodies for Cancer market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Bispecific Antibodies for Cancer volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bispecific Antibodies for Cancer market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Bispecific Antibodies for Cancer in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Bispecific Antibodies for Cancer manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Amgen
Astella Pharma
Ben Kang Biopharmaceutical (Shenzhen)
Merus
Regeneron Pharmaceuticals
…
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
CD19/CD3
CD30/CD16A
Segment by Application
Hospital
Pharmaceutical Companies
Other
Table of Contents
Executive Summary
1 Industry Overview of Bispecific Antibodies for Cancer
1.1 Definition of Bispecific Antibodies for Cancer
1.2 Bispecific Antibodies for Cancer Segment by Type
1.2.1 Global Bispecific Antibodies for Cancer Production Growth Rate Comparison by Types (2014-2025)
1.2.2 CD19/CD3
1.2.3 CD30/CD16A
1.3 Bispecific Antibodies for Cancer Segment by Applications
1.3.1 Global Bispecific Antibodies for Cancer Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Pharmaceutical Companies
1.3.4 Other
1.4 Global Bispecific Antibodies for Cancer Overall Market
1.4.1 Global Bispecific Antibodies for Cancer Revenue (2014-2025)
1.4.2 Global Bispecific Antibodies for Cancer Production (2014-2025)
1.4.3 North America Bispecific Antibodies for Cancer Status and Prospect (2014-2025)
1.4.4 Europe Bispecific Antibodies for Cancer Status and Prospect (2014-2025)
1.4.5 China Bispecific Antibodies for Cancer Status and Prospect (2014-2025)
1.4.6 Japan Bispecific Antibodies for Cancer Status and Prospect (2014-2025)
1.4.7 Southeast Asia Bispecific Antibodies for Cancer Status and Prospect (2014-2025)
1.4.8 India Bispecific Antibodies for Cancer Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Bispecific Antibodies for Cancer
2.3 Manufacturing Process Analysis of Bispecific Antibodies for Cancer
2.4 Industry Chain Structure of Bispecific Antibodies for Cancer
3 Development and Manufacturing Plants Analysis of Bispecific Antibodies for Cancer
3.1 Capacity and Commercial Production Date
3.2 Global Bispecific Antibodies for Cancer Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Bispecific Antibodies for Cancer
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Bispecific Antibodies for Cancer Production and Capacity Analysis
4.2 Bispecific Antibodies for Cancer Revenue Analysis
4.3 Bispecific Antibodies for Cancer Price Analysis
4.4 Market Concentration Degree
5 Bispecific Antibodies for Cancer Regional Market Analysis
5.1 Bispecific Antibodies for Cancer Production by Regions
5.1.1 Global Bispecific Antibodies for Cancer Production by Regions
5.1.2 Global Bispecific Antibodies for Cancer Revenue by Regions
5.2 Bispecific Antibodies for Cancer Consumption by Regions
5.3 North America Bispecific Antibodies for Cancer Market Analysis
5.3.1 North America Bispecific Antibodies for Cancer Production
5.3.2 North America Bispecific Antibodies for Cancer Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Bispecific Antibodies for Cancer Import and Export
5.4 Europe Bispecific Antibodies for Cancer Market Analysis
5.4.1 Europe Bispecific Antibodies for Cancer Production
5.4.2 Europe Bispecific Antibodies for Cancer Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Bispecific Antibodies for Cancer Import and Export
5.5 China Bispecific Antibodies for Cancer Market Analysis
5.5.1 China Bispecific Antibodies for Cancer Production
5.5.2 China Bispecific Antibodies for Cancer Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Bispecific Antibodies for Cancer Import and Export
5.6 Japan Bispecific Antibodies for Cancer Market Analysis
5.6.1 Japan Bispecific Antibodies for Cancer Production
5.6.2 Japan Bispecific Antibodies for Cancer Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Bispecific Antibodies for Cancer Import and Export
5.7 Southeast Asia Bispecific Antibodies for Cancer Market Analysis
5.7.1 Southeast Asia Bispecific Antibodies for Cancer Production
5.7.2 Southeast Asia Bispecific Antibodies for Cancer Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Bispecific Antibodies for Cancer Import and Export
5.8 India Bispecific Antibodies for Cancer Market Analysis
5.8.1 India Bispecific Antibodies for Cancer Production
5.8.2 India Bispecific Antibodies for Cancer Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Bispecific Antibodies for Cancer Import and Export
6 Bispecific Antibodies for Cancer Segment Market Analysis (by Type)
6.1 Global Bispecific Antibodies for Cancer Production by Type
6.2 Global Bispecific Antibodies for Cancer Revenue by Type
6.3 Bispecific Antibodies for Cancer Price by Type
7 Bispecific Antibodies for Cancer Segment Market Analysis (by Application)
7.1 Global Bispecific Antibodies for Cancer Consumption by Application
7.2 Global Bispecific Antibodies for Cancer Consumption Market Share by Application (2014-2019)
8 Bispecific Antibodies for Cancer Major Manufacturers Analysis
8.1 Amgen
8.1.1 Amgen Bispecific Antibodies for Cancer Production Sites and Area Served
8.1.2 Amgen Product Introduction, Application and Specification
8.1.3 Amgen Bispecific Antibodies for Cancer Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Astella Pharma
8.2.1 Astella Pharma Bispecific Antibodies for Cancer Production Sites and Area Served
8.2.2 Astella Pharma Product Introduction, Application and Specification
8.2.3 Astella Pharma Bispecific Antibodies for Cancer Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Ben Kang Biopharmaceutical (Shenzhen)
8.3.1 Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Production Sites and Area Served
8.3.2 Ben Kang Biopharmaceutical (Shenzhen) Product Introduction, Application and Specification
8.3.3 Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Merus
8.4.1 Merus Bispecific Antibodies for Cancer Production Sites and Area Served
8.4.2 Merus Product Introduction, Application and Specification
8.4.3 Merus Bispecific Antibodies for Cancer Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Regeneron Pharmaceuticals
8.5.1 Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Production Sites and Area Served
8.5.2 Regeneron Pharmaceuticals Product Introduction, Application and Specification
8.5.3 Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
9 Development Trend of Analysis of Bispecific Antibodies for Cancer Market
9.1 Global Bispecific Antibodies for Cancer Market Trend Analysis
9.1.1 Global Bispecific Antibodies for Cancer Market Size (Volume and Value) Forecast 2019-2025
9.2 Bispecific Antibodies for Cancer Regional Market Trend
9.2.1 North America Bispecific Antibodies for Cancer Forecast 2019-2025
9.2.2 Europe Bispecific Antibodies for Cancer Forecast 2019-2025
9.2.3 China Bispecific Antibodies for Cancer Forecast 2019-2025
9.2.4 Japan Bispecific Antibodies for Cancer Forecast 2019-2025
9.2.5 Southeast Asia Bispecific Antibodies for Cancer Forecast 2019-2025
9.2.6 India Bispecific Antibodies for Cancer Forecast 2019-2025
9.3 Bispecific Antibodies for Cancer Market Trend (Product Type)
9.4 Bispecific Antibodies for Cancer Market Trend (Application)
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Bispecific Antibodies for Cancer Distributors List
10.3 Bispecific Antibodies for Cancer Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Bispecific Antibodies for Cancer
Table Global Bispecific Antibodies for Cancer Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Bispecific Antibodies for Cancer Production Market Share by Types in 2018
Figure CD19/CD3 Product Picture
Figure CD30/CD16A Product Picture
Table Global Bispecific Antibodies for Cancer Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Bispecific Antibodies for Cancer Consumption Market Share by Applications in 2018
Figure Hospital
Figure Pharmaceutical Companies
Figure Other
Figure Global Bispecific Antibodies for Cancer Revenue (Million USD) (2014-2025)
Figure Global Bispecific Antibodies for Cancer Production (K Units) (2014-2025)
Figure North America Bispecific Antibodies for Cancer Market Size (Million USD) (2014-2025)
Figure Europe Bispecific Antibodies for Cancer Market Size (Million USD) (2014-2025)
Figure China Bispecific Antibodies for Cancer Market Size (Million USD) (2014-2025)
Figure Japan Bispecific Antibodies for Cancer Market Size (Million USD) (2014-2025)
Figure Southeast Asia Bispecific Antibodies for Cancer Market Size (Million USD) (2014-2025)
Figure India Bispecific Antibodies for Cancer Market Size (Million USD) (2014-2025)
Table Bispecific Antibodies for Cancer Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Bispecific Antibodies for Cancer in 2018
Figure Manufacturing Process Analysis of Bispecific Antibodies for Cancer
Figure Industry Chain Structure of Bispecific Antibodies for Cancer
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Bispecific Antibodies for Cancer Manufacturing Plants Distribution
Table Bispecific Antibodies for Cancer Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Bispecific Antibodies for Cancer Capacity (K Units) of Major Manufacturers (2014-2019)
Table Bispecific Antibodies for Cancer Production (K Units) of Major Manufacturers (2014-2019)
Table Bispecific Antibodies for Cancer Production Market Share of Major Manufacturers (2014-2019)
Figure Bispecific Antibodies for Cancer Production Share by Manufacturers in 2018
Table Bispecific Antibodies for Cancer Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Bispecific Antibodies for Cancer Revenue Market Share of Major Manufacturers (2014-2019)
Figure Bispecific Antibodies for Cancer Revenue Share by Manufacturers in 2018
Table Bispecific Antibodies for Cancer Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Bispecific Antibodies for Cancer Production by Regions 2014-2019 (K Units)
Table Global Bispecific Antibodies for Cancer Production Market Share by Regions 2014-2019
Figure Global Bispecific Antibodies for Cancer Production Market Share by Regions in 2018
Table Global Bispecific Antibodies for Cancer Revenue by Regions 2014-2019 (Million USD)
Table Global Bispecific Antibodies for Cancer Revenue Market Share by Regions 2014-2019
Figure Global Bispecific Antibodies for Cancer Revenue Market Share by Regions in 2018
Table Global Bispecific Antibodies for Cancer Consumption by Regions 2014-2019 (K Units)
Table Global Bispecific Antibodies for Cancer Consumption Market Share by Regions 2014-2019
Figure North America Bispecific Antibodies for Cancer Production Growth Rate 2014-2019 (K Units)
Figure North America Bispecific Antibodies for Cancer Revenue Growth Rate 2014-2019 (Million USD)
Table North America Bispecific Antibodies for Cancer Production, Consumption Import and Export (K Units)
Figure Europe Bispecific Antibodies for Cancer Production Growth Rate 2014-2019 (K Units)
Figure Europe Bispecific Antibodies for Cancer Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Bispecific Antibodies for Cancer Production, Consumption Import and Export (K Units)
Figure China Bispecific Antibodies for Cancer Production Growth Rate 2014-2019 (K Units)
Figure China Bispecific Antibodies for Cancer Revenue Growth Rate 2014-2019 (Million USD)
Table China Bispecific Antibodies for Cancer Production, Consumption Import and Export (K Units)
Figure Japan Bispecific Antibodies for Cancer Production Growth Rate 2014-2019 (K Units)
Figure Japan Bispecific Antibodies for Cancer Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Bispecific Antibodies for Cancer Production, Consumption Import and Export (K Units)
Figure Southeast Asia Bispecific Antibodies for Cancer Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Bispecific Antibodies for Cancer Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Bispecific Antibodies for Cancer Production, Consumption Import and Export (K Units)
Figure India Bispecific Antibodies for Cancer Production Growth Rate 2014-2019 (K Units)
Figure India Bispecific Antibodies for Cancer Revenue Growth Rate 2014-2019 (Million USD)
Table India Bispecific Antibodies for Cancer Production, Consumption Import and Export (K Units)
Figure Global Consumption Bispecific Antibodies for Cancer Market Share by Application (2014-2019)
Figure Global Value (Consumption) Bispecific Antibodies for Cancer Market Share by Application (2014-2019)
Table Amgen Bispecific Antibodies for Cancer Production Sites and Area Served
Table Amgen Bispecific Antibodies for Cancer Product Introduction, Application and Specification
Table Amgen Bispecific Antibodies for Cancer Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Bispecific Antibodies for Cancer Production Growth Rate (2014-2019)
Table Amgen Bispecific Antibodies for Cancer Production Market Share (2014-2019)
Figure Amgen Bispecific Antibodies for Cancer Revenue Market Share (2014-2019)
Table Amgen Bispecific Antibodies for Cancer Main Business and Markets Served
Table Astella Pharma Bispecific Antibodies for Cancer Production Sites and Area Served
Table Astella Pharma Bispecific Antibodies for Cancer Product Introduction, Application and Specification
Table Astella Pharma Bispecific Antibodies for Cancer Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Astella Pharma Bispecific Antibodies for Cancer Production Growth Rate (2014-2019)
Table Astella Pharma Bispecific Antibodies for Cancer Production Market Share (2014-2019)
Figure Astella Pharma Bispecific Antibodies for Cancer Revenue Market Share (2014-2019)
Table Astella Pharma Bispecific Antibodies for Cancer Main Business and Markets Served
Table Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Production Sites and Area Served
Table Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Product Introduction, Application and Specification
Table Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Production Growth Rate (2014-2019)
Table Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Production Market Share (2014-2019)
Figure Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Revenue Market Share (2014-2019)
Table Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Main Business and Markets Served
Table Merus Bispecific Antibodies for Cancer Production Sites and Area Served
Table Merus Bispecific Antibodies for Cancer Product Introduction, Application and Specification
Table Merus Bispecific Antibodies for Cancer Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merus Bispecific Antibodies for Cancer Production Growth Rate (2014-2019)
Table Merus Bispecific Antibodies for Cancer Production Market Share (2014-2019)
Figure Merus Bispecific Antibodies for Cancer Revenue Market Share (2014-2019)
Table Merus Bispecific Antibodies for Cancer Main Business and Markets Served
Table Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Production Sites and Area Served
Table Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Product Introduction, Application and Specification
Table Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Production Growth Rate (2014-2019)
Table Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Production Market Share (2014-2019)
Figure Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Revenue Market Share (2014-2019)
Table Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Main Business and Markets Served
Figure Global Bispecific Antibodies for Cancer Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Bispecific Antibodies for Cancer Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Bispecific Antibodies for Cancer Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Bispecific Antibodies for Cancer Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Bispecific Antibodies for Cancer Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Bispecific Antibodies for Cancer Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Bispecific Antibodies for Cancer Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Bispecific Antibodies for Cancer Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Bispecific Antibodies for Cancer Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Bispecific Antibodies for Cancer Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Bispecific Antibodies for Cancer Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Bispecific Antibodies for Cancer Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Bispecific Antibodies for Cancer Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Bispecific Antibodies for Cancer Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Bispecific Antibodies for Cancer Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Bispecific Antibodies for Cancer by Type (2019-2025)
Table Global Consumption (K Units) of Bispecific Antibodies for Cancer by Application (2019-2025)
Table Bispecific Antibodies for Cancer Distributors List
Table Bispecific Antibodies for Cancer Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
がんモノクローナル抗体の世界市場：インサイト・予測 The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from oth…- 乳がんモノクローナル抗体の世界市場：市場規模・現状・予測 Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protei…
- 世界の二重特異性抗体治療法市場：動向・競争分析 Bispecific antibodies (BsAbs) recognize two different epitopes. This dual specificity opens up a wide range of applications, including redirecting T cells to tumor cells, blocking two different signaling pathways simultaneously, dual targeting of different disease mediators, and delivering payloads …
- ナノ抗体の世界市場：市場規模・現状・予測 Nanoantibodies or "nAb" are single-domain VHH antibodies derived from camelidae (camels, llamas, alpacas, etc.). Compared with conventional monoclonal and polyclonal antibodies, nAbs have the following advantages: Small size (~15kd) High affinity (frequently nanomolar range) High specificity Unsurpa…
- HER2抗体の世界市場：市場規模・現状・予測 The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer. In 2018, the global HER2 Antibodies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% duri…